IP Case Law › Patents › Natera Inc. & Anr. v. The Assistant Controller of Patents an…
Relevant Acts and provisions
Patents Act, 1970
Section 10(4)Section 117ASection 2(1)(j)Section 2(1)(ja)Section 3(i)Section 59
Provisions considered: Sections 2(1)(j), 2(1)(ja), 3(i), 10(4), 59 and 117A of the Patents Act, 1970.
Brief facts
Natera Inc. and a co-applicant appealed against an order refusing a patent application for methods of lung cancer detection. Claims directed to tracking single-nucleotide variants associated with tumour mutations in individuals suspected of a specific carcinoma were refused as a diagnostic method under Section 3(i), and further claims restored after the hearing from the original international application were…
Free to read once you are signed in
Read the rest of this case note
The findings, the decision and the principle the court settled on are below. Create a free account to keep reading. No payment, and nothing to cancel.
Already have an account? Sign in
We use your details to give you access and to contact you about your enquiry. See our privacy policy.
Keywords
Biotechnology Claim Construction Patent Prosecution Section 3(i) Sufficiency Of Disclosure
Read the judgment
More Patents judgments
Patents
Array Biopharma Inc v. Deputy Controller of Patents and Designs
A combination of distinct and independent active drugs, each with its own chemical identity and mechanism, does not fall under the Section 3(d) bar for derivatives of known substances. Using phrases such as 'for simultaneous, sepa…
Inventive StepMethod of TreatmentPharmaceutical CombinationPrior ArtPatentsBayer Corporation v. Union of India & Ors.
A compulsory licence under Section 84 of the Patents Act, 1970 may be granted where the reasonable requirements of the public with respect to a patented invention have not been satisfied, the invention is not available at a reason…
Compulsory LicencePublic HealthReasonably Affordable PriceSection 84PatentsBigtec Private Limited v. Assistant Controller of Patents and Designs
An objection that devising nucleotide probes or primers is routine experimentation lacking inventive step under Section 2(1)(ja) must engage with evidence of unexpected effects placed on record; and the Section 3(c) exclusion for …
BiotechnologyInventive StepPatent ProsecutionPrior Art